Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422902 · ClinicalTrials.gov registry record · Phase 2
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
A Phase 2 study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT01422902 is a Phase 2 study that has completed, run by Posit Science Corporation. The registered enrollment target is 150 participants.
The verdict
NCT01422902, a Phase 2 study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study is a multi-site, double-blind, randomized, controlled clinical trial to assess the safety and effectiveness of plasticity-based, adaptive, computerized-based cognitive remediation treatment versus a computer-based control. The investigators proposed that a computerized cognitive remediation program based upon the principles of brain plasticity may improve information processing and thus drive clinically significant improvements in cognitive and functional performance in individuals with schizophrenia.
Interventions
- OTHER Plasticity-based Cognitive Training
- OTHER Non-plasticity-based Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422902
The ClinicalTrials.gov registry entry for NCT01422902 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Plasticity-based Cognitive Training is the first listed.
NCT01422902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01422902 about?
NCT01422902 is a clinical study titled "Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults". This study is a multi-site, double-blind, randomized, controlled clinical trial to assess the safety and effectiveness of plasticity-based, adaptive, computerized-based cognitive remediation treatment versus a computer-based control. The investigators proposed that a computerized cognitive remediat...
What is the current status of trial NCT01422902?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2012-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01422902?
The interventions under investigation include: Plasticity-based Cognitive Training (OTHER), Non-plasticity-based Training (OTHER).
Who is sponsoring clinical trial NCT01422902?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.